Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. 1983

R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon

Contrast-enhancing agents for demonstrating abnormalities of the blood-brain barrier may extend the diagnostic utility of proton nuclear magnetic resonance (NMR) imaging. "TES," a nitroxide stable free radical derivative, was tested as a central nervous system contrast enhancer in dogs with experimentally induced unilateral cerebritis or radiation cerebral damage. After intravenous injection of TES, the normal brain showed no change in NMR appearance, but areas of disease demonstrated a dramatic increase (up to 45%) in spin-echo intensity and a decrease in T1 relaxation times. The areas of disease defined by TES enhancement were either not evident on the nonenhanced NMR images or were better defined after contrast administration. In-depth tests of toxicity, stability, and metabolism of this promising NMR contrast agent are now in progress.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001930 Brain Injuries Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. Brain Lacerations,Acute Brain Injuries,Brain Injuries, Acute,Brain Injuries, Focal,Focal Brain Injuries,Injuries, Acute Brain,Injuries, Brain,Acute Brain Injury,Brain Injury,Brain Injury, Acute,Brain Injury, Focal,Brain Laceration,Focal Brain Injury,Injuries, Focal Brain,Injury, Acute Brain,Injury, Brain,Injury, Focal Brain,Laceration, Brain,Lacerations, Brain
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003497 Cyclic N-Oxides Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen. Heterocyclic N-Oxides,Cyclic N Oxides,Heterocyclic N Oxides,N Oxides, Cyclic,N-Oxides, Cyclic,N-Oxides, Heterocyclic,Oxides, Cyclic N
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004660 Encephalitis Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. Inflammation, Brain,Rasmussen Syndrome,Brain Inflammation,Encephalitis, Rasmussen,Rasmussen Encephalitis,Rasmussen's Syndrome,Brain Inflammations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
October 1983, Seminars in nuclear medicine,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
June 1994, Investigative radiology,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
August 1989, Journal of the American College of Cardiology,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
November 1988, Drug design and delivery,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
February 1985, Science (New York, N.Y.),
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
January 1986, American journal of physiologic imaging,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
February 2020, Nanoscale,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
March 1983, The Practitioner,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
September 1982, No to shinkei = Brain and nerve,
R C Brasch, and D E Nitecki, and M Brant-Zawadzki, and D R Enzmann, and G E Wesbey, and T N Tozer, and L D Tuck, and C E Cann, and J R Fike, and P Sheldon
May 1989, Investigative radiology,
Copied contents to your clipboard!